Apyx Medical Corporation
APYX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $48,102 | $52,349 | $44,510 | $48,517 |
| % Growth | -8.1% | 17.6% | -8.3% | – |
| Cost of Goods Sold | $18,742 | $18,590 | $15,379 | $14,916 |
| Gross Profit | $29,360 | $33,759 | $29,131 | $33,601 |
| % Margin | 61% | 64.5% | 65.4% | 69.3% |
| R&D Expenses | $5,080 | $4,844 | $4,544 | $4,321 |
| G&A Expenses | $43,125 | $48,866 | $48,149 | $43,728 |
| SG&A Expenses | $43,125 | $48,866 | $48,149 | $43,728 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$2,692 | $0 | $0 |
| Operating Expenses | $48,205 | $51,018 | $52,693 | $48,049 |
| Operating Income | -$18,845 | -$17,259 | -$23,562 | -$14,448 |
| % Margin | -39.2% | -33% | -52.9% | -29.8% |
| Other Income/Exp. Net | -$4,462 | -$4,023 | $651 | -$372 |
| Pre-Tax Income | -$23,307 | -$21,282 | -$22,911 | -$14,820 |
| Tax Expense | $252 | -$2,432 | $367 | $380 |
| Net Income | -$23,463 | -$18,713 | -$23,184 | -$15,172 |
| % Margin | -48.8% | -35.7% | -52.1% | -31.3% |
| EPS | -0.66 | -0.54 | -0.67 | -0.44 |
| % Growth | -22.2% | 19.4% | -52.3% | – |
| EPS Diluted | -0.66 | -0.54 | -0.67 | -0.44 |
| Weighted Avg Shares Out | 35,542 | 34,622 | 34,516 | 34,332 |
| Weighted Avg Shares Out Dil | 35,542 | 34,622 | 34,516 | 34,332 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,606 | $921 | $157 | $11 |
| Interest Expense | $5,907 | $2,478 | $15 | $10 |
| Depreciation & Amortization | $599 | $692 | $890 | $903 |
| EBITDA | -$16,801 | -$18,112 | -$22,006 | -$13,907 |
| % Margin | -34.9% | -34.6% | -49.4% | -28.7% |